iFocus Online #118
National Postgraduate Education Program

Glaucoma #22
Glaucomas Associated with Intraocular Hemorrhage by Dr Debasis Chakrabarti, Centre for Sight, Kolkata

Ocular Ultrasound Basics - Made Simple

Dr. Carvajal, Director of Developmental Therapeutics and Assistant Attending Physician at Memorial Sloan Kettering Cancer Center describes the future of immunotherapy and clinical trials for metastatic melanoma.

Agency: BoldSpark
Director: Sean Willis
BoldSparkCollective.com

Dr. Marcus Butler will be presenting ‘Expanding Horizons in Melanoma Treatment: Reaching for the goal of long term survival’
Marcus Butler is a medical oncologist with the Princess Margaret Cancer Centre and an Assistant Professor at the University of Toronto.

He cares for patients with melanoma and gynecologic malignancies and is the Clinical Head of the Immune Monitoring Team at Princess Margaret Cancer Centre.
His work focuses on the development of immunotherapy trials, which include studies, alone and in combination, of immune checkpoint blocking antibodies, immunomodulators, and adoptive cell transfer.

David Eschelman discusses liver directed treatment options for metastatic ocular melanoma.

Presented by David J. Eschelman, MD, FSIR from the Sidney Kimmel Medical College of Thomas Jefferson University at the 2018 CURE OM Patient Symposium.

Ashley Moyer, PA-C, MPAS, Physician Assistant at UPMC Hillman Cancer Center. The presentation is part of AIM at Melanoma’s Living with Melanoma Symposiums co-hosted with UPMC Hillman Cancer Center on April 13, 2019 in Pittsburgh, PA.

Adjuvant Melanoma Updates presented by Joanne Jeter, MD at the 2018 Columbus, OH Melanoma Patient Symposium hosted by the Melanoma Research Foundation and The James at The Ohio State University.